216 related articles for article (PubMed ID: 28921814)
1. Nabilone pharmacotherapy for cannabis dependence: A randomized, controlled pilot study.
Hill KP; Palastro MD; Gruber SA; Fitzmaurice GM; Greenfield SF; Lukas SE; Weiss RD
Am J Addict; 2017 Dec; 26(8):795-801. PubMed ID: 28921814
[TBL] [Abstract][Full Text] [Related]
2. Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial.
Levin FR; Mariani JJ; Pavlicova M; Brooks D; Glass A; Mahony A; Nunes EV; Bisaga A; Dakwar E; Carpenter KM; Sullivan MA; Choi JC
Drug Alcohol Depend; 2016 Feb; 159():53-60. PubMed ID: 26711160
[TBL] [Abstract][Full Text] [Related]
3. Separate and combined effects of the cannabinoid agonists nabilone and Δ⁹-THC in humans discriminating Δ⁹-THC.
Lile JA; Kelly TH; Hays LR
Drug Alcohol Depend; 2011 Jul; 116(1-3):86-92. PubMed ID: 21227600
[TBL] [Abstract][Full Text] [Related]
4. Varenicline and nabilone in tobacco and cannabis co-users: effects on tobacco abstinence, withdrawal and a laboratory model of cannabis relapse.
Herrmann ES; Cooper ZD; Bedi G; Ramesh D; Reed SC; Comer SD; Foltin RW; Haney M
Addict Biol; 2019 Jul; 24(4):765-776. PubMed ID: 30378231
[TBL] [Abstract][Full Text] [Related]
5. Nabiximols combined with motivational enhancement/cognitive behavioral therapy for the treatment of cannabis dependence: A pilot randomized clinical trial.
Trigo JM; Soliman A; Quilty LC; Fischer B; Rehm J; Selby P; Barnes AJ; Huestis MA; George TP; Streiner DL; Staios G; Le Foll B
PLoS One; 2018; 13(1):e0190768. PubMed ID: 29385147
[TBL] [Abstract][Full Text] [Related]
6. Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocol.
Bhardwaj AK; Allsop DJ; Copeland J; McGregor IS; Dunlop A; Shanahan M; Bruno R; Phung N; Montebello M; Sadler C; Gugusheff J; Jackson M; Luksza J; Lintzeris N;
BMC Psychiatry; 2018 May; 18(1):140. PubMed ID: 29776349
[TBL] [Abstract][Full Text] [Related]
7. Subjective, cognitive and cardiovascular dose-effect profile of nabilone and dronabinol in marijuana smokers.
Bedi G; Cooper ZD; Haney M
Addict Biol; 2013 Sep; 18(5):872-81. PubMed ID: 22260337
[TBL] [Abstract][Full Text] [Related]
8. Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and a laboratory model of relapse in cannabis users.
Herrmann ES; Cooper ZD; Bedi G; Ramesh D; Reed SC; Comer SD; Foltin RW; Haney M
Psychopharmacology (Berl); 2016 Jul; 233(13):2469-78. PubMed ID: 27085870
[TBL] [Abstract][Full Text] [Related]
9. Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial.
Allsop DJ; Copeland J; Lintzeris N; Dunlop AJ; Montebello M; Sadler C; Rivas GR; Holland RM; Muhleisen P; Norberg MM; Booth J; McGregor IS
JAMA Psychiatry; 2014 Mar; 71(3):281-91. PubMed ID: 24430917
[TBL] [Abstract][Full Text] [Related]
10. Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse.
Haney M; Cooper ZD; Bedi G; Vosburg SK; Comer SD; Foltin RW
Neuropsychopharmacology; 2013 Jul; 38(8):1557-65. PubMed ID: 23443718
[TBL] [Abstract][Full Text] [Related]
11. Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial.
Levin FR; Mariani JJ; Brooks DJ; Pavlicova M; Cheng W; Nunes EV
Drug Alcohol Depend; 2011 Jul; 116(1-3):142-50. PubMed ID: 21310551
[TBL] [Abstract][Full Text] [Related]
12. Vilazodone for cannabis dependence: A randomized, controlled pilot trial.
McRae-Clark AL; Baker NL; Gray KM; Killeen T; Hartwell KJ; Simonian SJ
Am J Addict; 2016 Jan; 25(1):69-75. PubMed ID: 26685701
[TBL] [Abstract][Full Text] [Related]
13. Buspirone treatment of cannabis dependence: A randomized, placebo-controlled trial.
McRae-Clark AL; Baker NL; Gray KM; Killeen TK; Wagner AM; Brady KT; DeVane CL; Norton J
Drug Alcohol Depend; 2015 Nov; 156():29-37. PubMed ID: 26386827
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of a fatty acid amide hydrolase inhibitor (PF-04457845) in the treatment of cannabis withdrawal and dependence in men: a double-blind, placebo-controlled, parallel group, phase 2a single-site randomised controlled trial.
D'Souza DC; Cortes-Briones J; Creatura G; Bluez G; Thurnauer H; Deaso E; Bielen K; Surti T; Radhakrishnan R; Gupta A; Gupta S; Cahill J; Sherif MA; Makriyannis A; Morgan PT; Ranganathan M; Skosnik PD
Lancet Psychiatry; 2019 Jan; 6(1):35-45. PubMed ID: 30528676
[TBL] [Abstract][Full Text] [Related]
15. Nabilone Impairs Spatial and Verbal Working Memory in Healthy Volunteers.
Kassim FM; Tod S; Rodger J; Hood SD; Lee JWY; Albrecht MA; Martin-Iverson MT
Cannabis Cannabinoid Res; 2024 Feb; 9(1):199-211. PubMed ID: 36201240
[No Abstract] [Full Text] [Related]
16. A Systematic Review of the Efficacy of Cannabinoid Agonist Replacement Therapy for Cannabis Withdrawal Symptoms.
Werneck MA; Kortas GT; de Andrade AG; Castaldelli-Maia JM
CNS Drugs; 2018 Dec; 32(12):1113-1129. PubMed ID: 30361897
[TBL] [Abstract][Full Text] [Related]
17. Use of a synthetic cannabinoid in a correctional population for posttraumatic stress disorder-related insomnia and nightmares, chronic pain, harm reduction, and other indications: a retrospective evaluation.
Cameron C; Watson D; Robinson J
J Clin Psychopharmacol; 2014 Oct; 34(5):559-64. PubMed ID: 24987795
[TBL] [Abstract][Full Text] [Related]
18. The Safety of Dronabinol and Nabilone: A Systematic Review and Meta-Analysis of Clinical Trials.
Bajtel Á; Kiss T; Tóth B; Kiss S; Hegyi P; Vörhendi N; Csupor-Löffler B; Gede N; Hohmann J; Csupor D
Pharmaceuticals (Basel); 2022 Jan; 15(1):. PubMed ID: 35056154
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain: A systematic review of randomized controlled studies].
Petzke F; Enax-Krumova EK; Häuser W
Schmerz; 2016 Feb; 30(1):62-88. PubMed ID: 26830780
[TBL] [Abstract][Full Text] [Related]
20. Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial.
Pini LA; Guerzoni S; Cainazzo MM; Ferrari A; Sarchielli P; Tiraferri I; Ciccarese M; Zappaterra M
J Headache Pain; 2012 Nov; 13(8):677-84. PubMed ID: 23070400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
